1.
138例入组患者的生存曲线。两组患者1年生存率分别为79%和67%（P=0.607）
Overall survival in 38 enrolled patients treated with induction chemotherapy and concurrent radiotherapy and paclitaxel. 1-year survival rate of two groups was 79% and 67%, respectively (P=0.607)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.